Signal active
Organization
Contact Information
Overview
Anubis Bio has USPTO patented Microbiome-Cleanser (TM) natural food platform that quickly resolves GI-distress-diarrhea in animals starting with dogs (www.doggystat.com). Two major B2B distribution partnerships signed in 2021.
About
Biotechnology, Pet, Health Care, Wellness, Dietary Supplements, Nutrition, Veterinary
2018
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Anubis Bio headquartered in United States, North America, operates in the Biotechnology, Pet, Health Care, Wellness, Dietary Supplements, Nutrition, Veterinary sector. The company focuses on Biotechnology and has secured $116.5M in funding across 112 round(s). With a team of 1-10 employees, Anubis Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Anubis Bio, raised $40.0K. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
4
1
0
$1.0M
Details
4
Anubis Bio has raised a total of $1.0M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2019 | Seed | |||
2020 | Seed | 1.0M | ||
2018 | Seed | |||
2019 | Early Stage Venture | 40.0K |
Investors
Anubis Bio is funded by 10 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Anubis Bio | - | FUNDING ROUND - Anubis Bio | undefined |
New York Angels | - | FUNDING ROUND - New York Angels | undefined |
Anubis Bio | - | FUNDING ROUND - Anubis Bio | 40.0K |
Lubbock Angel Network | - | FUNDING ROUND - Lubbock Angel Network | 40.0K |
Recent Activity
There is no recent news or activity for this profile.